DK23790D0 - Doseringsform til administrering af en calciumantagonist - Google Patents

Doseringsform til administrering af en calciumantagonist

Info

Publication number
DK23790D0
DK23790D0 DK023790A DK23790A DK23790D0 DK 23790 D0 DK23790 D0 DK 23790D0 DK 023790 A DK023790 A DK 023790A DK 23790 A DK23790 A DK 23790A DK 23790 D0 DK23790 D0 DK 23790D0
Authority
DK
Denmark
Prior art keywords
anagonist
administration
calcium
dosage form
dosage
Prior art date
Application number
DK023790A
Other languages
English (en)
Other versions
DK23790A (da
Inventor
Joseph C Deters
David R Swanson
Stephen C Derosa
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of DK23790D0 publication Critical patent/DK23790D0/da
Publication of DK23790A publication Critical patent/DK23790A/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK023790A 1989-01-30 1990-01-29 Doseringsform til administrering af en calciumantagonist DK23790A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30370689A 1989-01-30 1989-01-30

Publications (2)

Publication Number Publication Date
DK23790D0 true DK23790D0 (da) 1990-01-29
DK23790A DK23790A (da) 1990-07-31

Family

ID=23173326

Family Applications (1)

Application Number Title Priority Date Filing Date
DK023790A DK23790A (da) 1989-01-30 1990-01-29 Doseringsform til administrering af en calciumantagonist

Country Status (11)

Country Link
EP (1) EP0455648B1 (da)
JP (1) JPH04503058A (da)
AU (1) AU621182B2 (da)
CA (1) CA2007106A1 (da)
DK (1) DK23790A (da)
ES (2) ES2054333T3 (da)
FI (1) FI913608A7 (da)
GR (1) GR1000419B (da)
IE (1) IE61872B1 (da)
PT (1) PT92994B (da)
WO (1) WO1990008536A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ238867A (en) * 1990-07-12 1993-08-26 Alza Corp Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device
US5156850A (en) * 1990-08-31 1992-10-20 Alza Corporation Dosage form for time-varying patterns of drug delivery
US5654005A (en) * 1995-06-07 1997-08-05 Andrx Pharmaceuticals, Inc. Controlled release formulation having a preformed passageway
AU1534699A (en) * 1997-12-05 1999-06-28 Alza Corporation Osmotic dosage form comprising first and second coats
DE69917618T2 (de) 1998-04-03 2005-06-23 Egalet A/S Zusammensetzung mit kontrollierter wirkstoff-freisetzung
WO2003024430A1 (en) 2001-09-21 2003-03-27 Egalet A/S Morphine polymer release system
EP2957281A1 (en) 2001-09-21 2015-12-23 Egalet Ltd. Polymer release system
WO2004041252A1 (en) 2002-11-08 2004-05-21 Egalet A/S Controlled release carvedilol compositions
US8877241B2 (en) 2003-03-26 2014-11-04 Egalet Ltd. Morphine controlled release system
EP2186510B1 (en) 2003-03-26 2013-07-10 Egalet Ltd. Matrix compositions for controlled delivery of drug substances
WO2006030402A2 (en) * 2004-09-17 2006-03-23 Ranbaxy Laboratories Limited Dual compartment osmotic delivery device
EP1858492B1 (en) * 2005-01-27 2008-11-12 ALZA Corporation Oral osmotic dosage form having a high flux membrane
NZ580972A (en) 2007-06-04 2012-02-24 Egalet Ltd Controlled release pharmaceutical compositions for prolonged effect
WO2010089132A1 (en) 2009-02-06 2010-08-12 Egalet A/S Immediate release composition resistant to abuse by intake of alcohol
EP2445487A2 (en) 2009-06-24 2012-05-02 Egalet Ltd. Controlled release formulations
BR112015000150A2 (pt) 2012-07-06 2017-06-27 Egalet Ltd composições farmacêuticas dissuasoras de abuso de liberação controlada

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4519801A (en) * 1982-07-12 1985-05-28 Alza Corporation Osmotic device with wall comprising cellulose ether and permeability enhancer
US4783337A (en) * 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4753802A (en) * 1986-03-19 1988-06-28 Alza Corporation Verapamil dosage form

Also Published As

Publication number Publication date
GR900100015A (en) 1991-06-07
CA2007106A1 (en) 1990-07-30
DK23790A (da) 1990-07-31
GR1000419B (el) 1992-06-30
ES2054333T3 (es) 1994-08-01
PT92994B (pt) 1995-12-29
IE900296L (en) 1990-07-30
FI913608A0 (fi) 1991-07-29
EP0455648B1 (en) 1993-03-10
WO1990008536A1 (en) 1990-08-09
PT92994A (pt) 1990-07-31
JPH04503058A (ja) 1992-06-04
AU621182B2 (en) 1992-03-05
ES2026304A6 (es) 1992-04-16
IE61872B1 (en) 1994-11-30
AU4811490A (en) 1990-08-24
EP0455648A1 (en) 1991-11-13
FI913608A7 (fi) 1991-07-29

Similar Documents

Publication Publication Date Title
FI914765A7 (fi) Hidastetusti vapauttava oraalinen lääkeannosmuoto
DK1155695T3 (da) Anvendelse af en 1,3-oxathiolannukleosid-analog til fremstillingen af et lægemiddel til specifik indgivelse
DK180790D0 (da) Fremstilling af farmaceutisk praeparat
DK362189D0 (da) Farmaceutisk praeparat til intravenoes indgift
FI940787L (fi) Annostusmuoto lääkkeen annostelemiseksi lyhyessä ajanjaksossa
DK162877C (da) Depotplaster til indgift af et laegemiddel
NO302216B1 (no) Farmasöytisk doseringsform med nullte ordens frigivelse av en kalsiumantagonist av dihydropyridintypen
DK156376C (da) Anvendelse af ibogain til fremstilling af et laegemiddel til behandling af narkotikamisbrug
DK100488D0 (da) Farmaceutisk plaster
DK23790A (da) Doseringsform til administrering af en calciumantagonist
DK645788A (da) Anvendelse af ergolinderivater til fremstilling af et farmaceutisk praeparat
DK308488D0 (da) Farmaceutisk praeparat til behandling af en retrovirusinfektion
DK485688D0 (da) Doseringsform til levering af diltiazem
DK128589A (da) Anvendelse af piperidinmethanolderivater til fremstilling af et farmaceutisk praeparat
DK689188D0 (da) Anvendelse af piperidin-derivater til fremstilling af et farmaceutisk praeparat
DK473088A (da) Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til fremstilling af et laegemiddel
DK473288D0 (da) Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til fremstilling af et laegemiddel
DK265789D0 (da) Fremstilling af et farmaceutisk praeparat
DK137390D0 (da) Fremgangsmaade til fremstilling af en natriumpolyacrylatgel
DK651588A (da) Anvendelse af en forbindelse til fremstilling af et farmaceutisk praeparat til behandling af fibromyalgia
DK164021C (da) Anvendelse af diltiazem til fremstilling af et farmaceutisk praeparat til behandling af hyperlipidemi
DK37589A (da) Farmaceutisk praeparat for 4-aroylimidazol-2-oner
DK318689D0 (da) Anvendelse af lactamimider til fremstilling af calcium-antagonister
NO912497D0 (no) Doseringsform for administrering av kalsiumantagonist.
DK580488D0 (da) Fremgangsmaade til fremstilling af en tabletterbar laegemiddelblanding

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment